Revenue
2020
2021
2022
2023
2024
2025
2026
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $178,046 | $220,112 | $395,543 | $1.3M |
| Research & development | — | — | — | — | — | $114,356 | $56,299 |
| Operating expenses | $5.8M | $6.0M | $6.9M | $8.3M | $6.8M | $5.9M | $4.6M |
| Operating income | −$6.0M | −$6.0M | −$7.2M | −$8.3M | −$6.8M | — | — |
| Operating margin | — | — | — | −4,637.05% | −3,079.07% | — | — |
| EBITDA | −$5.8M | −$5.8M | −$7.0M | −$8.0M | −$6.6M | — | — |
| EBITDA margin | — | — | — | −4,517.12% | −3,000.01% | — | — |
| Net income | −$4.2M | −$3.8M | −$6.0M | −$8.1M | −$6.5M | −$6.6M | $5.9M |
| Net profit margin | — | — | — | −4,549.46% | −2,940.17% | −1,662.11% | 449.21% |
| Basic EPSper basic share | -$0.02 | -$0.02 | -$0.04 | -$0.05 | -$0.04 | -$0.04 | $0.04 |
| Diluted EPSper diluted share | -$0.02 | -$0.02 | -$0.04 | -$0.05 | -$0.04 | -$0.04 | $0.04 |
Reported shareholders